Press Releases

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals.    CAMBRIDGE Mass., October 15, 2025 — TriNetX, driven by its vision of a connected world where data and...

Recognition by The Healthcare Technology Report underscores TriNetX’s innovation in real-world data, artificial intelligence, and clinical research transformation.    CAMBRIDGE Mass., September 25, 2025 — TriNetX, the company behind the world’s broadest federated...

Analysis reveals strategic opportunities for pharmaceutical leaders to close treatment gaps and accelerate breakthroughs in underserved rare disease communities. Cambridge, MA, July 31, 2025 — TriNetX, driven by its vision of a connected world where data and...

Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum.   CAMBRIDGE, MA – July 10, 2025 – As...

Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan.      Cambridge, MA, February 12, 2025 — TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu,...

After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board   CAMBRIDGE, MA – January 9, 2025 – TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step...